Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial.
- N. K. Cheung(corresponding author),
- L. Burch,
- B. H. Kushner,
- Memorial Sloan-Kettering Cancer Center
Scholary Output:
Contribution to journal
Article
Peer-reviewPublication Information
Output type
Scholary Output:
Contribution to journal
Article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 395-400 (6 pages)Journal (Volume, Issue Number)
Progress in clinical and biological research (Volume 366)Publication milestones
- Published - 1991
Publication status
Published - 1991
ISSN
0361-7742Publication IDs
- Scopus: 0026041422
- PubMed: 2068154
- ORCID: /0000-0002-7711-2858/work/58011281
Access to documents
Publication metrics
Metrics
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
PlumX
Captures
7
Citation count
27